GTXI Key Stats
- GTx's CEO Discusses Q3 2013 Results - Earnings Call Transcript Seeking Alpha Nov 12
- GTx, Inc. Earnings Call scheduled for 9:00 am ET today Nov 12
- GTx, Inc. Discusses Q2 2013 Results (Webcast) Seeking Alpha Nov 12
- GTx, Inc. (GTXI) Reports Smaller Q3 Loss Street Insider Nov 12
- GTx Provides Corporate Update and Reports Third Quarter 2013 Financial Results noodls Nov 12
- Q3 2013 GTx, Inc. Earnings Release - Before Market Open Nov 12
- GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits Nov 12
- Trading Radar for 11/12: DISH Network (DISH), Potbelly (PBPB), Dick's (DKS), Yingli Green Energy (YGE) Report Street Insider Nov 11
- GIGABYTE Takes The Lead to Announce Own Designed GeForce® GTX 780 Ti ... noodls Nov 8
- Nvidia Launches GTX 780 Ti -- Faster Than Titan For $300 Less Forbes Nov 7
GTXI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GTx is down 60.15% over the last year vs S&P 500 Total Return up 29.68%, StemCells down 35.79%, and Sarepta Therapeutics down 34.86%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for GTXI
Pro Strategies Featuring GTXI
Did GTx make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
GTx, Inc. is biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition.